- Home
- KALV vs FFWM Comparison
KALV vs FFWM Comparison
Compare KALV & FFWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- FFWM
- Stock Information
- Founded
- KALV N/A
- FFWM 1990
- Country
- KALV United States
- FFWM United States
- Employees
- KALV N/A
- FFWM N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- FFWM Major Banks
- Sector
- KALV Health Care
- FFWM Finance
- Exchange
- KALV Nasdaq
- FFWM Nasdaq
- Market Cap
- KALV 362.2M
- FFWM 409.3M
- IPO Year
- KALV N/A
- FFWM 2014
- Fundamental
- Price
- KALV $10.03
- FFWM $5.01
- Analyst Decision
- KALV Strong Buy
- FFWM Buy
- Analyst Count
- KALV 8
- FFWM 4
- Target Price
- KALV $25.67
- FFWM $6.75
- AVG Volume (30 Days)
- KALV 321.8K
- FFWM 572.2K
- Earning Date
- KALV 03-10-2025
- FFWM 01-30-2025
- Dividend Yield
- KALV N/A
- FFWM 0.19%
- EPS Growth
- KALV N/A
- FFWM N/A
- EPS
- KALV N/A
- FFWM N/A
- Revenue
- KALV N/A
- FFWM $96,072,000.00
- Revenue This Year
- KALV N/A
- FFWM N/A
- Revenue Next Year
- KALV N/A
- FFWM $12.73
- P/E Ratio
- KALV N/A
- FFWM N/A
- Revenue Growth
- KALV N/A
- FFWM N/A
- 52 Week Low
- KALV $7.30
- FFWM $4.66
- 52 Week High
- KALV $15.50
- FFWM $8.52
- Technical
- Relative Strength Index (RSI)
- KALV 59.09
- FFWM 35.49
- Support Level
- KALV $8.99
- FFWM $5.07
- Resistance Level
- KALV $11.00
- FFWM $5.40
- Average True Range (ATR)
- KALV 0.57
- FFWM 0.22
- MACD
- KALV 0.11
- FFWM 0.01
- Stochastic Oscillator
- KALV 57.08
- FFWM 40.70
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.